Intrapleural Minocycline After Aspiration of Spontaneous Pneumothorax

Status Recruiting

Clinical Trial Summary

The estimated recurrence rate of primary spontaneous pneumothorax is 23-50% after the first episode, and the optimal treatment remains unknown. In the recently published British Thoracic Society (BTS) guidelines, simple aspiration is recommended as first line treatment for all primary pneumothoraces requiring intervention. However, the 1 year recurrence rate of this procedure was as high as 25-30%, making it inappropriate as a standard of care.

Intrapleural instillation of a chemical irritant (chemical pleurodesis) is an effective way to shorten the duration of air leaks and reduce the rates of recurrent spontaneous pneumothorax in surgical and non-surgical patients. Many chemical irritants (tetracycline, talc, and minocycline) have been used to decrease the rate of recurrence in spontaneous pneumothorax. Tetracycline, which was the most commonly used irritant, is no longer available. Talc insufflation of the pleural cavity is safe and effective for primary spontaneous pneumothorax. However, it should be applied either with surgical or medical thoracoscopy. Minocycline, a derivative of tetracycline, is as effective as tetracycline in inducing pleural fibrosis in rabbits. In the previous studies, we have shown that additional minocycline pleurodesis is a safe and convenient procedure to decrease the rates of ipsilateral recurrence after thoracoscopic treatment of primary spontaneous pneumothorax. In the present study, additional minocycline pleurodesis will be randomly administered in patients with first episode of primary spontaneous pneumothorax after simple aspiration. The primary goal is to test if intrapleural minocycline can reduce the rate of recurrence. The secondary goals are to evaluate the safety profile, short-term results, and long-term effects of minocycline pleurodesis after simple aspiration. The sites of study include National Taiwan University Hospital and Far Eastern Memorial Hospital. A total of 300 patients (150 patients in each arm) will be included for this study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Pneumothorax

Clinical Trial Details

NCT number	NCT00839553
Study type	Interventional
Source	Far Eastern Memorial Hospital
Contact	Kuang-Chau Tsai, Master
Phone	886-2-89667000
Email	hikali@mail.femh.org.tw
Status	Recruiting
Phase	N/A
Start date	April 2007
Completion date	April 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06022081` - Lung Ultrasound Versus Chest Radiography for Detection of Pneumothorax	N/A
Recruiting	`NCT02907866` - Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study
Terminated	`NCT03034421` - Prevention of Pneumothorax Following Endoscopic Valve Therapy in Patients With Severe Emphysema	N/A
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT02619591` - Comparison Of Chest Ultrasound Techniques To Identify Clinically Significant Pneumothorax	N/A
Recruiting	`NCT05342675` - Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy	N/A
Recruiting	`NCT05910112` - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed	`NCT03656406` - Effect of Lateral Positioning on Bronchial Cuff Pressure of Left-sided Double-lumen Endotracheal Tube During Thoracic Surgery
Active, not recruiting	`NCT06075836` - AI Assisted Detection of Chest X-Rays
Recruiting	`NCT03728491` - Education and Training Competences in Thoracic Ultrasound	N/A
Recruiting	`NCT05407974` - Pleurectomy Versus Pleural Abrasion in Patients With Spontaneous Pneumothorax	N/A
Completed	`NCT01670942` - Hypobaria and Traumatic Pneumothorax	N/A
Terminated	`NCT00969423` - Chronic Pain After Video-assisted Thoracoscopic Surgery (VATS) Surgery for Pneumothorax	N/A
Completed	`NCT05904574` - Effectiveness of the Autologous Blood Patch Method in Lung Biopsies
Completed	`NCT03327688` - Point-of-care Ultrasound in Finland	N/A
Completed	`NCT05963945` - Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
Completed	`NCT05222568` - Effect of the Minimum Bronchial Cuff Volume of Left-sided Double-lumen Endotracheal Tube for One-lung Ventilation on the Change of the Bronchial Cuff Pressure During Lateral Positioning in Thoracic Surgery
Not yet recruiting	`NCT05121233` - Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures	Phase 4
Completed	`NCT03064659` - Driving Pressure And EFL in Adult Cardiac Surgery	N/A
Recruiting	`NCT02090205` - Mechanical Ventilation During Cardiac Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.